Members |
targetComponentId |
Tibiofibular ligament (& distal) |
Structure of ligament of distal tibiofibular joint |
Tic |
Tic disorder |
Tic |
Tic disorder |
Tic |
Tic disorder |
Tic |
Tic (finding) |
Tic |
Tic (finding) |
Tic |
Tic (finding) |
Tic disorder |
Tic disorder |
Tic disorder |
Tic (finding) |
Ticarcillin and clavulanic acid adverse reaction |
Adverse reaction to clavulanic acid and/or ticarcillin |
Ticarcillin disodium with clavulanate potassium |
Clavulanate potassium (substance) |
Ticarcillin disodium with clavulanate potassium |
Ticarcillin disodium |
Tick bite without infection |
Tick bite |
Tick bite without infection |
Bite of tick (event) |
Tick paralysis causing toxic effect |
Tick paralysis |
Tick-borne bunyavirus encephalitis |
Nairoviral encephalitis (disorder) |
Tick-borne bunyavirus fever |
Tick-borne orthobunyavirus fever |
Tick-borne bunyavirus fever |
Disease caused by Nairovirus (disorder) |
Tick-borne encephalitis vaccine |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne encephalitis vaccine |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne encephalitis vaccine injection solution prefilled syringe |
Tick-borne encephalitis virus antigen-containing vaccine product |
Tick-borne flavivirus encephalitis |
Tick-borne encephalitis |
Tick-borne flavivirus encephalitis |
Encephalitis due to tick-borne encephalitis virus subgroup |
Tick-borne viral encephalitis |
Viral encephalitis transmitted by tick |
Tick-borne viral encephalitis |
Tick-borne encephalitis |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
Ability to sense tickle (observable entity) |
Tidal river |
Tidal river (environment) |
Tidal river |
Tidal river water (substance) |
Tile &/or slab caster |
Slab caster |
Tile &/or slab caster |
Slab caster |
Tile &/or slab caster |
Tile/slab caster |
Tile &/or slab caster |
Tile/slab caster |
Tile &/or slab caster |
Tile caster |
Tiler |
Floor/wall tiler (occupation) |
Tiler |
Floor/wall tiler (occupation) |
Tiler |
Tiler |
Tiler |
Tiler |
Time duration (property) (qualifier value) |
Time (attribute) |
Time duration (property) (qualifier value) |
Time (property) (qualifier value) |
Timed six meter walk |
Timed six metre walk technique |
Timed six meter walk |
Timed six meter walk time (observable entity) |
Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
Timolol 0.25% liquid eye gel |
Timolol (as timolol maleate) 2.5 mg/mL eye gel |
Timolol 0.5% eye drops preservative free |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol 0.5% liquid eye gel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye gel (clinical drug) |
Timothy grass |
Phleum |
Timothy grass |
Phleum pratense (organism) |
Timothy grass pollen allergen |
Timothy grass pollen (substance) |
Tinamou |
Family Tinamidae (organism) |
Tinamou |
Order Tinamiformes (organism) |
Tinea barbae |
Deep bacterial folliculitis (disorder) |
Tinea barbae |
Tinea barbae (disorder) |
Tinea barbae |
Bacterial folliculitis (disorder) |
Tinea barbae |
Pseudofolliculitis barbae (disorder) |
Tinea cruris |
Tinea cruris (disorder) |
Tinea cruris |
Tinea of perianal region (disorder) |
Tinea nigra |
Microsporosis nigra |
Tinea nigra |
Infection by Cladosporium werneckii |
Tinea nigra |
Tinea nigra |
Tinea pedis caused by combined/concurrent infection |
Tinea pedis |
Tinea profunda |
Tinea profunda |
Tinea profunda |
Deep seated dermatophytosis |
Tinea unguium |
Onychomycosis (disorder) |
Tinea unguium |
Onychomycosis due to dermatophyte |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
Tingling: [sensation] or [has sensation] |
Tingling of skin |
Tinzaparin sodium 10,000iu/mL injection solution 0.25mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 0.35mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 0.45mL prefilled syringe |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 10,000iu/mL injection solution 2mL vial |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.5mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.7mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 0.9mL prefilled syringe |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tinzaparin sodium 20,000iu/mL injection solution 2mL vial |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tioconazole 28% solution |
Tioconazole 283 mg/mL cutaneous solution |
Tissierella species |
Tissierella |
Tissue cell sample |
Cytologic material |
Tissue frozen section technique, complete |
Tissue frozen section technique |
Tissue saturation oximeter sensor, reprocessed |
Oxygen sensor (physical object) |
Tissue saturation oximeter sensor, single-use |
Oxygen sensor (physical object) |
Tissue specimen from lung |
Specimen from lung obtained by biopsy |
Tissue specimen from lung |
Tissue specimen from lung (specimen) |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Tobacco smoking consumption |
Tobacco dependence (& [dependent smoker]) |
Tobacco dependence syndrome |
Toboggan dermatitis |
Frictional lichenoid eruption (disorder) |
Toboggan dermatitis |
Friction dermatitis of children |
Tobramycin 40mg/mL injection solution 1mL ampule |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tobramycin 40mg/mL injection solution 2mL ampule |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Tobramycin [eye] |
Product containing tobramycin in ocular dose form (medicinal product form) |
Tobramycin [respiratory use] |
Product containing tobramycin in pulmonary dose form (medicinal product form) |
Toe: [Perionychia] or [cellulitis and abscess NOS] |
Paronychia of toe (disorder) |
Toe: [Perionychia] or [cellulitis and abscess NOS] |
Onychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Paronychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Onychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Paronychia of toe (disorder) |
Toe: [cellulitis] or [paronychia] |
Cellulitis of toe |
Toe: [cellulitis] or [paronychia] |
Onychia of toe (disorder) |